dvm360 Flex Forecast highlights OA, derm, marketing, and parvo CE: full analysis
dvm360’s Flex Forecast for May and June 2026 packages four on-demand webinars into a concise snapshot of what veterinary teams are being encouraged to learn now: osteoarthritis prevention, feline dermatology and diet trials, client-facing marketing, and canine parvovirus treatment strategy. The sessions feature Janice Huntingford, DVM, MS-TCVM, DACVSMR, CVA, CVPP, CCRV; Julia E. Miller, DVM, DACVD; Kevin Brongers; and Tannetje Crocker, DVM, respectively, and they’re available through dvm360’s continuing education platform. (ce.dvm360.com)
The timing fits a broader seasonal push in veterinary education. dvm360’s May 4, 2026 conference calendar points to a crowded late-spring and early-summer CE landscape, from NAVC SkillShop in Orlando on May 24-28 to Fetch Nashville on May 29-30, UC Davis AggieVet on May 30-31, ACVIM Forum in Seattle on June 11-13, and PacVet in Sacramento on June 18-21. In other words, Flex isn’t appearing in a vacuum; it’s part of a wider effort to meet clinicians where they are, whether that means travel-based conferences, hybrid learning, or on-demand modules that can be completed around hospital schedules. (dvm360.com)
The clinical sessions are practical rather than abstract. Huntingford’s osteoarthritis webinar, “Osteoarthritis-Not just an old dog disease,” centers on prevention, early risk identification, and evidence-based use of supplements and nutraceuticals before OA becomes clinically obvious. Miller’s feline dermatology program, “Itchy and I Won’t Eat That! Navigating Feline Dermatoses in the Picky Eater,” focuses on cat diet trials, including case selection, diet choice, and how to handle poor palatability in finicky patients. Those topics line up with growing interest in earlier mobility intervention and more realistic dermatology plans that account for what cats and pet parents will actually accept at home. (ce.dvm360.com)
The nonclinical and infectious disease offerings fill out the picture. Brongers’ “Authentic Marketing: Building Lifelong Client Connections” frames marketing as an extension of care and emphasizes Google Business optimization, reviews, local SEO, social storytelling, and community engagement. Meanwhile, Crocker’s parvo webinar follows a case from first phone call through diagnosis and treatment, with attention to standard inpatient and outpatient care, communication strategies, and the possible role of canine parvovirus monoclonal antibody, or CPMA. (ce.dvm360.com)
That parvo angle matters because the treatment landscape has been moving. Elanco said in a 2025 update that USDA approved CPMA for passive immunity to help prevent parvo infection in exposed puppies, expanding beyond treatment use. Elanco’s pet parent-facing materials describe CPMA as the first and only USDA-conditionally approved, one-dose parvo treatment, while Merck Veterinary Manual now includes monoclonal antibody therapy among treatment considerations and notes that outpatient protocols can reach about an 80% success rate in reported settings. AAHA’s parvovirus resources also continue to stress that young dogs remain vulnerable when protective antibodies are lacking, particularly in shelter-linked populations. (elanco.com)
Industry perspective is a little easier to infer than to quote directly here, but the webinar descriptions themselves are revealing. dvm360’s CE catalog shows a steady mix of medicine, operations, and communication content, suggesting organizers see these competencies as interconnected rather than separate tracks. The marketing module’s emphasis on Google presence and reviews also matches broader veterinary marketing commentary that local search visibility and review generation are now foundational for practice discovery, especially for community-based hospitals competing for new-client demand. That’s an inference from the CE mix and outside marketing analysis, but it’s a reasonable one. (ce.dvm360.com)
Why it matters: For veterinarians, technicians, and practice leaders, this forecast is useful less because it announces brand-new science and more because it highlights where continuing education is being concentrated. Early OA recognition can change case trajectories. Better diet-trial execution can improve dermatology workups in cats that don’t cooperate with textbook plans. Updated parvo education is clinically relevant as monoclonal antibody options gain attention. And the inclusion of marketing alongside clinical content is a reminder that pet parent communication, online reputation, and local visibility increasingly affect whether patients reach the practice in time to benefit from care. (ce.dvm360.com)
What to watch: The next signal will be whether later 2026 Flex programming continues this same blend of hands-on medicine, client communication, and business execution, and whether parvo CE increasingly shifts from awareness to protocol-level guidance as clinics gain more experience with CPMA and related treatment pathways. (ce.dvm360.com)